Yesterday, I spoke to a group of antitrust practitioners and those involved in healthcare policy at AAI’s Healthcare Roundtable, where I discussed past and present FTC work to promote competition healthcare markets.
Imagine a series of promotions that involve pain relief promises, cognition claims, endorsements, 30-minute radio ads, “risk-free” money-back guarantees, “free” trial offers, negative options, telemarketing, and upsells of buying club memberships. What could possibly go wrong for consumers?
Where would you like to start?
To facilitate the transfer of data, many U.S. companies that do business internationally participate in the Asia-Pacific Economic Cooperation Cross-Border Privacy Rules (CBPR) system. It’s voluntary, of course, but if companies say they participate, that representation – like other objective claims – must be truthful. That’s the lesson of three proposed settlements just announced by the FTC.
Congress unanimously passed the Consumer Review Fairness Act to protect people’s ability to share in any forum their honest opinions about a business’ products, services, or conduct. Some companies had been using contract provisions – including their online terms and conditions – to threaten to sue consumers or penalize them financially for posting negative reviews or complaints. The new law makes that illegal.